Pfizer (PFE) Price to FCF (2009 - 2026)

Pfizer (PFE) has reported Price to FCF for 18 consecutive years, with 458.43 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to FCF rose 499.98% year-over-year to 458.43 in Q2 2026; TTM through Jun 2026 was 12.6, a 79.99% decrease from a year earlier, with the FY2025 full-year figure at 15.6, up 2.06% from the prior year.
• Price to FCF was 458.43 for Q2 2026 at Pfizer, up from 70.73 in the prior quarter.
• Over five years, Price to FCF peaked at 3155.19 in Q2 2023 and troughed at 114.61 in Q2 2025.
• A 5-year average of 294.88 and a median of 40.22 in 2024 frame the typical range for Price to FCF.
• The widest YoY moves for Price to FCF: up 6331.32% in 2023, down 346.82% in 2023.
• Over 5 years, Price to FCF stood at 39.54 in 2022, then slipped by 2.01% to 38.74 in 2023, then grew by 5.55% to 40.9 in 2024, then fell by 23.12% to 31.44 in 2025, then soared by 1357.96% to 458.43 in 2026.
• The last three Price to FCF figures came in at 458.43 (Q2 2026), 70.73 (Q1 2026), and 31.44 (Q4 2025), per Business Quant data.